Company record
NEWAMSTERDAM PHARMA B.V.
- B.V.
Signals
4 on record
- EPO patentsPatent
Patent publication EP4836758A1 by NewAmsterdam Pharma B.V.: PHARMACEUTICAL COMPOSITIONS OF OBICETRAPIB.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4836757A1 by NewAmsterdam Pharma B.V.: FIXED DOSE COMBINATION COMPOSITION OF OBICETRAPIB AND EZETIMIBE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4836777A1 by NewAmsterdam Pharma B.V.: IMPROVEMENT IN ATHEROSCLEROTIC PLAQUE CHARACTERISTICS WITH OBICETRAPIB.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026229390A1 by NEWAMSTERDAM PHARMA B.V.: OBICETRAPIB AND PCSK9 INHIBITOR FOR LOWERING LP(A) IN PATIENTS SUFFERING FROM DYSLIPIDEMIA.
EPO patentsRelevance21
Watch · 80% confidence